Trial NCT04433910; EudraCT 2020-001310-38
Publication CAPSID - Koerper S, J Clin Invest (2021) (published paper)
Primary outcome on the report: Dichotomous composite outcome of survival and no longer requiring ventilation support or ICU treatment and no tachypnea (i.e., respiratory rate <30 breaths/minute) on day 21.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.